Study guide

1.1 Signs of Pregnancy, hCG Kinetics & Acceptance of Pregnancy

AMCB Certified Nurse-Midwife CNM

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Early Pregnancy — Diagnosis, History, Dating & Models of Care

1.1 Signs of Pregnancy, hCG Kinetics & Acceptance of Pregnancy 1.2 Prenatal History, Obstetric Notation & Gestational Dating 1.3 The Initial Prenatal Laboratory Panel 1.4 Prenatal Genetic Screening, Diagnostic Testing & Hereditary Risk 1.5 Models of Prenatal Care, Birth-Setting Counseling & Community Referral

2 Chapter 2: Ongoing Prenatal Assessment, Nutrition & Common Discomforts

2.1 Prenatal Visit Cadence, Milestone Screening & Fundal Height 2.2 Leopold Maneuvers, Fetal Heart Auscultation & Antepartum Surveillance 2.3 Clinical Pelvimetry & Assessment of the Bony Pelvis 2.4 Maternal Nutrition, Weight Gain & Immunization in Pregnancy 2.5 Nausea, Vomiting & Gastrointestinal Discomforts of Pregnancy 2.6 Musculoskeletal, Vascular & Neurologic Discomforts of Pregnancy

3 Chapter 3: Hypertensive, Endocrine & Hematologic Complications of Pregnancy

3.1 Classification & Diagnosis of Hypertensive Disorders of Pregnancy 3.2 Acute Severe Hypertension, Magnesium Sulfate & Eclampsia 3.3 Delivery Timing, Aspirin Prophylaxis & Postpartum Hypertension 3.4 Gestational Diabetes: Pathophysiology, Screening & Diagnosis 3.5 Glycemic Management, Fetal Surveillance & Delivery Timing in Gestational Diabetes 3.6 Thyroid Disorders & Anemia in Pregnancy

4 Chapter 4: Bleeding, Amniotic Fluid Disorders, Preterm Birth & Perinatal Loss

4.1 First-Trimester Bleeding, Early Pregnancy Loss & Gestational Trophoblastic Disease 4.2 Ectopic Pregnancy: Diagnosis & Management 4.3 Third-Trimester Bleeding & Amniotic Fluid Volume Disorders 4.4 Preterm Labor & Preterm Prelabor Rupture of Membranes 4.5 Intrauterine Fetal Demise, Stillbirth & Bereavement Care

5 Chapter 5: Normal Labor, Birth & Intrapartum Fetal Surveillance

5.1 Onset of Labor, True Versus False Labor & Nutrition in Labor 5.2 The First and Second Stages of Labor 5.3 Cardinal Movements, Third & Fourth Stages of Labor 5.4 Cord Clamping, Cord Blood, Cord Gases & Placental Examination 5.5 Fetal Oxygenation, Intermittent Auscultation & Uterine Activity Monitoring 5.6 Electronic Fetal Monitoring Parameters & the NICHD Categories 5.7 Intrauterine Resuscitation, Scalp Electrode & Amnioinfusion

6 Chapter 6: Labor Support, Analgesia, Induction & Augmentation

6.1 The Midwifery Model, Continuous Labor Support & Non-Pharmacologic Comfort 6.2 Water Immersion, Waterbirth & Non-Supine Birth Positions 6.3 Systemic, Neuraxial & Regional Analgesia in Labor 6.4 Indications & Timing for Induction of Labor 6.5 The Bishop Score & Cervical Ripening Methods 6.6 Oxytocin Titration, Tachysystole Management & Amniotomy

7 Chapter 7: Intrapartum Emergencies, Malpresentation & Perineal Repair

7.1 Shoulder Dystocia: Recognition & the HELPERR Protocol 7.2 Dystocia Complications, Umbilical Cord Prolapse & Intraamniotic Infection 7.3 Malposition, Manual Rotation, Breech, Face Presentation & Nuchal Cord 7.4 Perineal Anatomy & Classification of Obstetric Lacerations 7.5 Episiotomy & Surgical Perineal Repair 7.6 TOLAC, VBAC & Uterine Rupture

8 Chapter 8: The Normal Puerperium, Postpartum Assessment & Lactation

8.1 Puerperal Physiology, Uterine Involution & Lochia 8.2 The BUBBLE-HE Postpartum Assessment 8.3 Bladder, Bowel & Perineal Care and the Postpartum Care Continuum 8.4 Lactation Neuroendocrinology & the Stages of Lactogenesis 8.5 LATCH Assessment, Latch Biomechanics & Adequate Intake 8.6 Lactation Complications, Medication Safety & Contraindications

9 Chapter 9: Postpartum Contraception, Family Planning & Hemorrhage

9.1 Return of Fertility, Lactational Amenorrhea & US MEC in the Puerperium 9.2 Postpartum Hormonal Contraception & Intrauterine Devices 9.3 Barrier & Permanent Contraception, Postpartum Sexuality & Family Support 9.4 Postpartum Hemorrhage: Definition, Shock Recognition & Quantitative Blood Loss 9.5 The Four Ts: Etiology of Postpartum Hemorrhage 9.6 Hemorrhage Resuscitation, Uterotonics, TXA & Surgical Escalation

10 Chapter 10: Puerperal Infection, Thromboembolism, Cesarean Recovery & Perinatal Mental Health

10.1 Puerperal Endometritis & Septic Pelvic Thrombophlebitis 10.2 Puerperal Wound Infection, Mastitis & Breast Abscess 10.3 Postpartum Venous Thromboembolism 10.4 Post-Cesarean Recovery: Inpatient Care & Care After Discharge 10.5 Postpartum Blues, Depression & EPDS Screening 10.6 Treating Postpartum Depression, Anxiety, OCD & Psychosis

11 Chapter 11: Neonatal Transition, Resuscitation & the Newborn Examination

11.1 Fetal-to-Neonatal Transition & Circulatory Remodeling 11.2 APGAR Scoring & the NRP Initial Steps 11.3 Positive Pressure Ventilation, MR. SOPA & Advanced Resuscitation 11.4 Newborn Vital Signs, Anthropometrics & the Ballard Score 11.5 Cranial Assessment & Head-to-Chest Examination 11.6 Genitourinary & Musculoskeletal Examination and Primitive Reflexes

12 Chapter 12: Newborn Prophylaxis, Screening, Common Disorders & Care Through 28 Days

12.1 Standard Neonatal Prophylaxis: Vitamin K, Eye Ointment & Hepatitis B 12.2 Universal Newborn Screening: Hearing, CCHD & Dried Blood Spot 12.3 Neonatal Hypoglycemia, Thermoregulation & the Infant of a Diabetic Mother 12.4 Neonatal Hyperbilirubinemia & Phototherapy 12.5 Infant Feeding Education, Circumcision Counseling & Care Through 28 Days

13 Chapter 13: Well-Woman Preventive Care, Cancer Screening & Immunization

13.1 The Well-Woman Visit & Cervical Cancer Screening 13.2 ASCCP Risk-Based Management & Breast Cancer Screening 13.3 Colorectal Cancer & Osteoporosis Screening 13.4 Adult Immunization & Environmental and Occupational Exposure Screening

14 Chapter 14: Contraception, Abortion Care & Fertility Evaluation

14.1 Contraceptive Efficacy Tiers & Long-Acting Reversible Contraception 14.2 Combined Hormonal Contraception 14.3 Progestin-Only Methods & Emergency Contraception 14.4 Abortion Care: Options Counseling, Medication Abortion & Follow-Up 14.5 Initial Infertility Evaluation & Gynecologic Imaging Referral

15 Chapter 15: Benign Gynecologic Conditions, Pelvic Floor & Menstrual Disorders

15.1 Endometriosis & Adenomyosis 15.2 Pelvic Organ Prolapse & Urinary Incontinence 15.3 Adnexal Masses, Malignancy Red Flags & Vulvar Disease 15.4 The Normal Menstrual Cycle & Anticipatory Guidance 15.5 The FIGO PALM-COEIN Classification of Abnormal Uterine Bleeding 15.6 Evaluating Abnormal Uterine Bleeding & the Amenorrhea Workup 15.7 Polycystic Ovary Syndrome

16 Chapter 16: Vaginitis, Sexually Transmitted Infections, Sexual Health & Menopause

16.1 Differential Diagnosis of Vaginitis & Bacterial Vaginosis 16.2 Candidiasis, Trichomoniasis, Chlamydia & Gonorrhea 16.3 Pelvic Inflammatory Disease 16.4 Genital Herpes, Syphilis & Anogenital Warts 16.5 Sexual Health Assessment, Sexual Function & Care After Sexual Assault 16.6 Reproductive Aging, Menopause Definitions & Clinical Manifestations 16.7 Menopausal Hormone Therapy 16.8 Non-Hormonal Therapies & Postmenopausal Osteoporosis

17 Chapter 17: Primary Care — Chronic Disease & Common Acute Conditions

17.1 Midwifery Primary Care Scope & Hypertension Management 17.2 Antihypertensive Pharmacotherapy & Hyperlipidemia 17.3 Type 2 Diabetes & Thyroid Disease in Primary Care 17.4 Respiratory Infections, Asthma & Urinary Tract Infection 17.5 Gastrointestinal & Dermatologic Conditions 17.6 Mental Health Screening & Substance Use Disorders 17.7 Intimate Partner Violence, Reproductive Coercion & Human Trafficking

18 Chapter 18: Midwifery Scope of Practice, Ethics, Collaboration & Health Equity

18.1 Regulatory Foundation of Practice & the Midwifery Model of Care 18.2 Bioethics, Informed Refusal & Collaborative Practice 18.3 Maternal Health Disparities, Structural Racism & Inclusive Care

1.1 Signs of Pregnancy, hCG Kinetics & Acceptance of Pregnancy

Key Takeaways Explain This Topic AI

Only three findings are positive (diagnostic) signs of pregnancy: sonographic visualization of the embryo or fetus, examiner-auscultated fetal heart tones, and examiner-palpated fetal movement.

A positive hCG assay is a probable sign, not a positive sign, because gestational trophoblastic disease and rare germ-cell tumors also secrete hCG.

In a viable intrauterine pregnancy before 6 to 7 weeks, serum hCG rises at least 50% in 48 hours; a sub-50% rise, plateau, or fall requires evaluation for ectopic pregnancy or early pregnancy failure.

ACOG sets the transvaginal discriminatory zone at 3,500 mIU/mL rather than 1,500 to 2,000 mIU/mL to avoid interrupting viable desired intrauterine pregnancies.

Pregnancy failure is definitively diagnosed at a crown-rump length of 7 mm or greater with no cardiac activity, or a mean gestational sac diameter of 25 mm or greater with no embryo.

Last updated: September 2026

Why Pregnancy Diagnosis Is Still Examined

Most patients arrive at the midwife's office already holding a positive home test, so it is tempting to treat pregnancy diagnosis as settled. The AMCB blueprint opens with the task "evaluates for signs of pregnancy" because the certified nurse-midwife (CNM) must be able to confirm or refute pregnancy when the history is unreliable, when a test result conflicts with the exam, and when an apparently normal early pregnancy is actually a failing intrauterine pregnancy, an ectopic gestation, or a molar pregnancy. Classic sign terminology is also heavily tested because it maps directly onto diagnostic certainty.

The Three Categories of Pregnancy Signs

Signs of pregnancy are graded by how much diagnostic weight they carry. Only positive signs are diagnostic; everything else has a differential.

Category Who Detects It Signs Typical Timing Why It Is Not Diagnostic

Presumptive The patient (subjective symptoms) Amenorrhea, nausea and vomiting, breast tenderness and enlargement, urinary frequency, fatigue, quickening, skin changes (linea nigra, melasma, striae) 4–20 weeks Every one of these occurs with thyroid disease, stress, hyperprolactinemia, gastrointestinal illness, premenstrual change, or peristalsis misread as fetal movement

Probable The clinician (objective signs) Goodell sign (cervical softening, ~6 weeks), Chadwick sign (bluish-violet vaginal and cervical mucosa, ~6–8 weeks), Hegar sign (softening/compressibility of the lower uterine segment, ~6–12 weeks), Piskacek sign (asymmetric uterine enlargement at the implantation cornu), uterine enlargement, Braxton Hicks contractions, ballottement (16–20 weeks), positive hCG assay 6–20 weeks Pelvic congestion, uterine leiomyomata, and adenomyosis mimic the physical signs; hCG is also produced by gestational trophoblastic disease and, rarely, by germ-cell tumors

Positive The clinician (fetus itself) Fetal heart tones auscultated by the examiner (Doppler 10–12 weeks; fetoscope/Pinard 18–20 weeks), sonographic visualization of the embryo or fetus , fetal movements palpated by the examiner (~20 weeks) 5–20 weeks None — these require a fetus to be present

Important

A positive urine pregnancy test is a probable sign, not a positive one. On the AMCB exam, the only findings that confirm pregnancy are those generated by the fetus: sonographic visualization, examiner-auscultated fetal heart tones, and examiner-palpated fetal movement.

Biochemical Confirmation: hCG Kinetics

Human chorionic gonadotropin (hCG) is secreted by syncytiotrophoblast from the time of implantation, roughly 6–10 days after fertilization.

Urine assays detect hCG at approximately 20–25 mIU/mL , which is reached around the first day of the missed menses. A negative urine test in a patient who is fewer than 7 days past a missed period does not exclude pregnancy — repeat in one week or draw a serum quantitative level.

Serum quantitative hCG becomes positive at 1–2 mIU/mL, roughly 8–11 days after conception.

Rise rate: in a viable intrauterine pregnancy before 6–7 weeks, serum hCG rises by a minimum of about 50% in 48 hours (the older "doubles every 48–72 hours" teaching is the average, not the floor). A sub-50% rise, a plateau, or a fall is abnormal and requires evaluation for ectopic pregnancy or early pregnancy failure.

Peak and plateau: hCG peaks at 8–10 weeks (often 50,000–100,000 mIU/mL), then declines and plateaus near 10,000–20,000 mIU/mL for the remainder of pregnancy.

Markedly higher than expected values suggest multifetal gestation or gestational trophoblastic disease ; markedly lower values suggest miscalculated dates, failing pregnancy, or ectopic implantation.

Serial hCG Interpretation

Serial levels are ordered when the location or viability of a pregnancy is uncertain, never as a routine dating tool.

Draw the first quantitative hCG with a transvaginal ultrasound whenever possible.

Repeat in 48 hours using the same laboratory and assay.

Interpret the trend plus the ultrasound , never the absolute number alone.

The discriminatory zone is the serum hCG level above which a normal intrauterine gestational sac should be visible on transvaginal ultrasound. ACOG now advises a conservative threshold of 3,500 mIU/mL rather than the historic 1,500–2,000 mIU/mL, because using a lower cutoff has caused viable desired intrauterine pregnancies to be interrupted as presumed ectopics.

Early Sonographic Landmarks

Transvaginal ultrasound establishes both viability and location. The following milestones are high-yield:

  • Structure Earliest Transvaginal Appearance
  • Intrauterine gestational sac 4.5–5.0 weeks
  • Yolk sac 5.0–5.5 weeks
  • Fetal (embryonic) pole 5.5–6.0 weeks
  • Cardiac activity By 6.0 weeks (crown-rump length ~2–4 mm)

Society of Radiologists in Ultrasound criteria define pregnancy failure as a crown-rump length ≥7 mm with no cardiac activity or a mean gestational sac diameter ≥25 mm with no embryo . These are definitive findings, not suspicious ones, and they prevent premature intervention on a viable pregnancy.

Assessing Acceptance of Pregnancy and Psychosocial Response

The blueprint pairs pregnancy diagnosis with the task "assesses the woman's acceptance of pregnancy." Confirming a pregnancy is a psychosocial event as much as a biochemical one.

Open the conversation neutrally: "How do you feel about this news?" rather than "Congratulations!" Roughly 45% of US pregnancies are unintended , and premature celebration closes off options counseling.

Ambivalence in the first trimester is normal , not pathologic. Reva Rubin described maternal role attainment as a sequenced set of tasks — seeking safe passage, securing acceptance from significant others, binding-in to the unknown child, and giving of oneself — that unfolds across the whole pregnancy; Ramona Mercer's Becoming a Mother framework extends this through the first year postpartum.

Screen at the confirmation visit for intimate partner violence, depression and anxiety, substance use, and housing or food insecurity , all of which shape whether a pregnancy is experienced as wanted.

Offer non-directive options counseling — continuation with parenting, adoption, or termination — and document the patient's stated intention. Support the patient's decision without steering it.

Support role transition by naming the concrete changes ahead, involving partners and existing children when the patient wishes, and referring for peer support, group prenatal care, or perinatal mental health services when the response to the diagnosis is distress rather than ambivalence.